SCHEMBL3401724

SCHEMBL3401724

CCCCCC(CCCCC)=C(CCCCC)CCCCC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 4/20 0.56
CES1 P23141 4/20 0.56
AKR1B1 P15121 1/20 0.53
GPR84 Q9NQS5 7/20 0.50
PPARG P37231 7/20 0.50
PPARD Q03181 7/20 0.50
PPARA Q07869 7/20 0.50
TSHR P16473 5/20 0.50
HDAC11 Q96DB2 5/20 0.50
PTPN1 P18031 3/20 0.50
ALDH1A1 P00352 2/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
FABP4 P15090 2/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
MEN1 O00255 1/20 0.50
ESR1 P03372 1/20 0.50
ALOX15 P16050 1/20 0.50
PDE4A P27815 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1527621 0.96 CES2 (0.58) CES2CES1GPR84PPARGPPARD
SCHEMBL5689910 0.96 CES2 (0.58) CES2CES1GPR84PPARGPPARD
SCHEMBL11239831 0.96 CES2 (0.58) CES2CES1GPR84PPARGPPARD
SCHEMBL10349515 0.93 CES2 (0.55) CES2CES1GPR84PPARGPPARD
Ammonia Solution, Strong SCHEMBL20801523 0.93 CES2 (0.55) CES2CES1GPR84PPARGPPARD
Ammonia Solution, Strong SCHEMBL179727 0.93 CES2 (0.55) CES2CES1GPR84PPARGPPARD
Ammonia Solution, Strong SCHEMBL11778398 0.93 CES2 (0.55) CES2CES1GPR84PPARGPPARD
SCHEMBL4791139 0.90 CES2 (0.48) CES2CES1AKR1B1GPR84PPARG
Ammonia Solution, Strong SCHEMBL6861504 0.90 CES2 (0.52) CES2CES1GPR84PPARGPPARD
SCHEMBL28958962 0.90 CES2 (0.52) CES2CES1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200041494-A1 MARKER AND SENSING SYSTEM USING THE SAME TOSHIBA KK (JP) 2020-02-06 US claimed
US-20170160270-A1 MARKER AND SENSING SYSTEM USING THE SAME TOSHIBA TEC KABUSHIKI KAISHA (JP) 2017-06-08 US claimed
US-20200041494-A1 MARKER AND SENSING SYSTEM USING THE SAME TOSHIBA KK (JP) 2020-02-06 US disclosed
US-20170160270-A1 MARKER AND SENSING SYSTEM USING THE SAME TOSHIBA TEC KABUSHIKI KAISHA (JP) 2017-06-08 US disclosed
US-8829783-B2 Trinaphthyl monoamine or derivative thereof, organic electroluminescent device using the same, and organic electroluminescent material-containing solution IDEMITSU KOSAN CO., LTD. (JP) 2014-09-09 US disclosed
US-20100156285-A1 TRINAPHTHYL MONOAMINE OR DERIVATIVE THEREOF, ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME, AND ORGANIC ELECTROLUMINESCENT MATERIAL-CONTAINING SOLUTION IDEMITSU KOSAN CO., LTD. (JP) 2010-06-24 US disclosed
US-7423382-B2 Light-emitting body, light emitting device and light-emitting display SAMSUNG SDI CO., LTD. (KR) 2008-09-09 US disclosed
US-20050067947-A1 Light-emitting body, light emitting device and light-emitting display SAMSUNG DISPLAY CO., LTD. (KR) 2005-03-31 US disclosed
US-6806643-B2 Light-emitting body, light emitting device and light-emitting display SAMSUNG SDI CO., LTD. (KR) 2004-10-19 US disclosed
US-20020167280-A1 Light-emitting body, light emitting device and light-emitting display SAMSUNG DISPLAY CO., LTD. (KR) 2002-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100156285-A1 TRINAPHTHYL MONOAMINE OR DERIVATIVE THEREOF, ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME, AND ORGANIC ELECTROLUMINESCENT MATERIAL-CONTAINING SOLUTION MAOA, COMT, MAOB CES2 339/4885CES1 3473/4885AKR1B1 3449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.